UPMC Cancer Center Passavant (OHA) — Pittsburgh, Pennsylvania

UPMC Cancer Center Passavant (OHA) is a clinical research site located in Pittsburgh, Pennsylvania, United States 15237.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

UPMC Cancer Center Passavant (OHA) has participated in 1 clinical trials.

Therapeutic areas: Advanced Breast Cancer (Female).

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPMC Cancer Center Passavant (OHA)?

UPMC Cancer Center Passavant (OHA) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPMC Cancer Center Passavant (OHA) conducted?

UPMC Cancer Center Passavant (OHA) has 1 clinical trials on record. Their work covers Advanced Breast Cancer (Female).

Is UPMC Cancer Center Passavant (OHA) accredited by Crixeo Health?

UPMC Cancer Center Passavant (OHA) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPMC Cancer Center Passavant (OHA)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.